Feed CPRX
CP

Catalyst Pharmaceuticals CPRX NASDAQ · Zdravstvo · Združene države Amerike

$31.49 -0.02% -$0.01

Market cap
$3.85B
Enterprise value
$3.10B
P/E
17.4x
Forward P/E
-
PEG
0.6x
P/S
6.5x
P/FCF
18.5x
EV/EBITDA
11.1x
ROIC
19.7%
Bruto marža
122.0%
Neto marža
37.1%
Dividend yield
-
Payout ratio
-
Neto dolg/EBITDA
-2.7x
Beta
0.74
Free float
94.4%

O podjetju

Catalyst Pharmaceuticals, Inc. (CPRX) is an American biopharmaceutical company specializing in research, development, and commercialization of drugs for rare neurological disorders. With activities in biotechnology and pharmacology, Catalyst Pharmaceuticals is a key player in the world of innovative treatment approaches. Their research focuses on discovering new treatment options and therapies for patients with neurological disorders, such as Lambert-Eaton myasthenic syndrome (LEMS). The company aims to provide modern treatment solutions and improve the quality of life for patients with rare diseases. Catalyst Pharmaceuticals is characterized by expertise in pharmacology and neurology. Catalyst Pharmaceuticals, Inc. (CPRX) shares could be suitable for investors looking for an investment opportunity in the biopharmaceutical sector with a company that specializes in innovative treatment approaches and therapies for patients with rare neurological disorders.

Sektor

Zdravstvo

Panoga

Biotechnology

CEO

Richard John Daly

Zaposleni

182

Sedež

Coral Gables

Vrednotenje

Je današnja cena primerna?

Rast in ocene

Ali podjetje raste in kaj sledi?

  • Kaj govori v prid: Dobiček na delnico je v zadnjih 3 letih rasel za 31 % letno.

Donosnost in kakovost

Koliko prihodkov ostane in kako dobro podjetje uporablja kapital?

  • Kaj govori v prid: Od vsakih 100 USD prihodkov ostane 37 USD čistega dobička.
  • Kaj govori v prid: Na vsakih 100 USD vloženega kapitala zasluži 20 USD letno.

Finančno zdravje

Ali zmore svoj dolg?

  • Kaj govori v prid: Ima več denarja kot dolga: $517,6M proti $3,19M.

Kapital in dividende

Kaj podjetje počne z zasluženim denarjem?

Analitiki

Kaj menijo strokovnjaki in ali se to spreminja?

Lastniki in insajderji

Kdo ima delnice in kaj počne vodstvo?

Segmenti

Kateri del podjetja raste?

Primerjava s konkurenco

Kako se primerja s podobnimi podjetji?

Cena in tveganje

Kako se delnica obnaša?

Izkazi

Vse številke

Uporabljamo nujne piškotke za delovanje spletnega mesta in izbirne analitične piškotke za merjenje uporabe.